Status:
ACTIVE_NOT_RECRUITING
Technology-assisted Language Intervention (TALI)
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Hearing Loss, Bilateral
Language Development
Eligibility:
All Genders
3-10 years
Phase:
NA
Brief Summary
This study is testing the effectiveness of augmentative and alternative communication technology among deaf or hard of hearing children for improving language development. Children will be randomized ...
Eligibility Criteria
Inclusion
- Age 3-10 years
- Documented permanent bilateral hearing loss with severity levels clinically defined moderate to profound).
- Identified with a language deficit, defined by either the ratio of language standard scores to nonverbal intelligence quotient \<.85 or a differences in nonverbal IQ and language standard scores of 10 points. Language scores may either be receptive or expressive.
- Currently receiving speech-language therapy.
Exclusion
- Mild hearing loss and unilateral hearing loss
- primary language other than English
- significant motor impairments
- nonverbal IQ \<80
- children with severe communication disorders (i.e. autism spectrum disorders).
Key Trial Info
Start Date :
October 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT04857255
Start Date
October 15 2020
End Date
March 31 2026
Last Update
August 27 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Colorado
Aurora, Colorado, United States, 80045
2
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229